SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Citi Cuts Tasly Pharmaceutical Revenue and EPS Estimates

Citi analysts cite tighter hospital controls on traditional Chinese medicine injections and weaker cold-medicine demand. They cut revenue estimates by 4% for 2026 and 6% each for 2027 and 2028, and EPS estimates by 3% for t…

600535

Related stories